Sun Nelson
See Remarks
Sun Nelson has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Sep 12, 2026.
On the most recent filing, Sun Nelson is listed as See Remarks at Aardvark Therapeutics, Inc. Inside the rolling window, Sun Nelson reported 1 open-market purchase totaling $43K in AARD and 2 open-market sales totaling $395K in AARD. The largest disclosed transaction in the window is a sale of 62,000 AARD shares on Sep 11, 2026, worth $321K.
Companies traded
Other insiders at AARD
Insider Buying
$43K
reported purchases (SEC code P)
Insider Selling
$395K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 9, 2025 | AARD | Purchase | $48K |
Frequently asked questions
How many SEC Form 4 filings has Sun Nelson made?
Sun Nelson has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Sun Nelson trade?
Sun Nelson has filed SEC Form 4 disclosures for 1 company, including AARD.
When was Sun Nelson's most recent SEC Form 4 filing?
Sun Nelson's most recent SEC Form 4 filing on Tracefour is dated Sep 12, 2026.
What is Sun Nelson's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sun Nelson is listed as See Remarks.
What is Sun Nelson's total buy and sell value in the current window?
Inside the rolling retention window, Sun Nelson bought $43K and sold $395K based on SEC Form 4 filings.
What was Sun Nelson's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 62,000 AARD shares on 2026-09-11, worth $321K, per SEC Form 4 filings.